As a global leader in drug development, Sarah Cannon has made countless contributions to advancing cancer therapies for more than two decades. Our research experts will highlight the latest data from studies across tumor types through more than 90 presentations at the Annual Meeting. Come see us at booth #3079.

View Press Release

About Sarah Cannon

Sarah Cannon Research Institute, the research arm of HCA Healthcare’s global cancer institute, Sarah Cannon, is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom. A leader in drug development, Sarah Cannon has led more than 260 first-in-man clinical trials since its inception in 1993, and has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years.

Learn more about Sarah Cannon.

Media Contacts

Sarah Cannon physicians and leadership are available for interview at the 2017 ASCO® Annual Meeting. Please contact the below regarding media opportunities.

Gabrielle Hannafan

Samantha Maxwell